Protara Therapeutics, Inc. (TARA)
2.70
-0.06
(-2.17%)
USD |
NASDAQ |
Oct 02, 16:00
2.695
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Market Cap : 159.53M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 159.53M |
| October 01, 2026 | 163.07M |
| September 30, 2026 | 180.21M |
| September 29, 2026 | 189.66M |
| September 28, 2026 | 192.02M |
| September 25, 2026 | 193.80M |
| September 24, 2026 | 197.93M |
| September 23, 2026 | 209.16M |
| September 22, 2026 | 217.43M |
| September 21, 2026 | 207.38M |
| September 18, 2026 | 209.75M |
| September 17, 2026 | 218.61M |
| September 16, 2026 | 213.88M |
| September 15, 2026 | 221.56M |
| September 14, 2026 | 231.02M |
| September 11, 2026 | 225.70M |
| September 10, 2026 | 223.93M |
| September 09, 2026 | 226.29M |
| September 08, 2026 | 229.84M |
| September 04, 2026 | 232.79M |
| September 03, 2026 | 234.56M |
| September 02, 2026 | 232.79M |
| September 01, 2026 | 230.43M |
| August 31, 2026 | 228.06M |
| August 28, 2026 | 225.70M |
| Date | Value |
|---|---|
| August 27, 2026 | 235.74M |
| August 26, 2026 | 231.02M |
| August 25, 2026 | 234.56M |
| August 24, 2026 | 228.65M |
| August 21, 2026 | 227.47M |
| August 20, 2026 | 230.43M |
| August 19, 2026 | 233.97M |
| August 18, 2026 | 235.15M |
| August 17, 2026 | 235.15M |
| August 14, 2026 | 234.56M |
| August 13, 2026 | 232.79M |
| August 12, 2026 | 229.84M |
| August 11, 2026 | 231.02M |
| August 10, 2026 | 242.83M |
| August 07, 2026 | 243.43M |
| August 06, 2026 | 242.24M |
| August 05, 2026 | 220.22M |
| August 04, 2026 | 220.77M |
| August 03, 2026 | 218.57M |
| July 31, 2026 | 215.82M |
| July 30, 2026 | 221.87M |
| July 29, 2026 | 209.76M |
| July 28, 2026 | 216.92M |
| July 27, 2026 | 222.42M |
| July 24, 2026 | 221.32M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.4687M |
| Brainstorm Cell Therapeutics, Inc. | 10.26M |
| Summit Therapeutics, Inc. | 13.29B |
| Kezar Life Sciences, Inc. | 53.76M |
| Clene, Inc. | 52.14M |
Market Cap Related Metrics
| Price to Book Value | 0.9889 |
| Price | 2.70 |
| Earnings Yield | -50.14% |